420.00p+0.00 (+0.00%)02 Jan 2025, 17:15
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.AJ Bell logo

Oxford Biomedica PLC Shares News & Articles

Oxford Biomedica’s first half impacted by rapid decline in Covid-19 vaccine demand

- Rapid decline for Covid-19 vaccine hits 1H revenues- Company expects to meet full year revenue expectations- Hopes pinned on transformational dealGene and cell therapy pharma services company Oxford Biomedica (OXB) said first half revenues fell 21% year-on-year to £64 million driven by a 24% reduction in Covid-19 vaccine manufacturing sales to £57.3 million.The fall in revenues, combined with
Showing 1 to 20 of 62